MCH Test

Your red blood cells exist for one reason: to shuttle oxygen from your lungs to every organ, muscle, and tissue in your body. The molecule that does the actual carrying is hemoglobin, a protein loaded with iron. MCH (mean corpuscular hemoglobin) tells you the average weight of hemoglobin inside each red blood cell, measured in picograms. When that number drops, each cell carries less oxygen than it should. When it rises, something is pushing your cells to grow larger or pack in more hemoglobin than normal. Either shift points to a process worth investigating.

Unlike many lab values that fluctuate with meals, stress, or time of day, MCH is remarkably stable. Your result reflects weeks to months of red blood cell production in your bone marrow. That makes it a reliable snapshot of whether your body has the raw materials it needs (iron, vitamin B12, folate) and whether the machinery assembling hemoglobin is working properly.

What MCH Actually Tells You

MCH is not measured directly. It is calculated by dividing your total hemoglobin concentration by your red blood cell count. The result, expressed in picograms (trillionths of a gram), captures how much hemoglobin the average red blood cell contains. A normal MCH generally falls between 27 and 33 pg in adults.

A low MCH means your red blood cells are under-loaded with hemoglobin, a condition called hypochromia. Under a microscope, these cells look pale in the center. The most common cause by far is iron deficiency: without enough iron, your bone marrow cannot build complete hemoglobin molecules, so each cell leaves the factory lighter than it should be. Inherited conditions like thalassemia (genetic disorders that reduce hemoglobin production) also drive MCH down.

A high MCH typically means your red blood cells are larger than normal. This happens when vitamin B12 or folate is low, because these nutrients are essential for DNA synthesis during cell division. Without them, developing red blood cells in the bone marrow cannot divide properly, so they grow oversized and carry extra hemoglobin. Liver disease and heavy alcohol use can also push MCH upward.

Mortality Risk: The U-Shaped Curve

A study of over 21,000 U.S. adults followed for an average of nearly 14 years found that MCH has a U-shaped relationship with death from any cause. The lowest risk sat at an inflection point of about 30.2 pg. Below that point, each 1 pg drop in MCH was associated with roughly 5% higher mortality risk (adjusted HR 1.05). Above that point, each 1 pg rise was associated with about 8% higher risk (adjusted HR 1.08). Both ends of the spectrum carried increased cardiovascular mortality as well.

This pattern held after adjusting for demographic and clinical risk factors. The takeaway is straightforward: very low and very high MCH values both signal something is off, and the sweet spot appears to be around 30 pg. If your value sits comfortably in the middle of the reference range, that is where you want to be.

Cancer Risk

A large study from the UK Biobank followed nearly 456,000 cancer-free participants for a median of about 11 years, during which over 47,000 new cancers were diagnosed. People in the highest fifth of MCH values had about 17% lower cancer risk across all types compared to those in the lowest fifth (adjusted HR 0.83). The relationship was nonlinear, and inverse associations appeared for lymphoma, leukemia, breast cancer, and kidney cancer specifically.

These findings do not mean a high MCH protects you from cancer. They suggest that MCH may serve as a marker of underlying nutritional and metabolic status that tracks with cancer susceptibility. This is an area where the science is still developing, and a single MCH reading should not drive cancer screening decisions.

Heart Disease and Acute Coronary Events

In a study of 393 people who had experienced an acute coronary event (heart attack or unstable angina), higher MCH independently predicted future major adverse cardiovascular events, but only in patients who were not anemic. In anemic patients, the association disappeared. The follow-up was about 31 months. This suggests MCH may carry prognostic value in specific cardiovascular populations, though the study was relatively small and these findings need replication.

An Early Clue to Iron Overload

Most people think of low MCH as the problem to watch for, but an elevated MCH can be one of the earliest signals of hereditary hemochromatosis, a genetic condition where the body absorbs too much iron from food. When iron is plentiful, red blood cells have no trouble loading up on hemoglobin, and MCH rises.

One study found that an MCH above 31 pg detected HFE gene mutations (the most common genetic cause of hemochromatosis) with 82% sensitivity and 78% specificity. Research confirms that elevations in MCH and MCV are among the earliest signs of hemochromatosis, sometimes appearing before ferritin levels rise. If your MCH is consistently above 31 to 32 pg and you are of Northern European descent, it is worth checking iron studies and potentially genetic testing for HFE mutations.

Reference Ranges

MCH values differ by age, sex, and ethnicity, and no single set of cutpoints fits everyone perfectly. That said, the following tiers, drawn from published population studies and clinical thresholds, give you a framework for interpreting your result.

These tiers are drawn from published research. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend.

Thalassemia Screening Thresholds

MCH plays a specific role in thalassemia carrier screening. Most beta-thalassemia and alpha-thalassemia carriers have an MCH below 27 pg. In one study of antenatal screening, an MCH at or above 28 pg had 100% sensitivity for ruling out alpha-thalassemia mutations, meaning no carriers were missed above that threshold. If you have ancestry from the Mediterranean, Middle East, Southeast Asia, or sub-Saharan Africa and your MCH is below 27 pg with normal iron studies, thalassemia carrier testing is a reasonable next step.

Sex and Age Differences

MCH increases gradually through childhood and reaches adult levels around puberty. After puberty, men tend to have slightly higher MCH values than women. Studies from multiple populations (Canadian, Chinese, German, Scandinavian) confirm that sex-specific and age-specific reference ranges provide more accurate interpretation than a single universal cutpoint.

Interestingly, mortality associations with MCH appear to differ by sex. A study of adults aged 75 to 80 found that higher MCH was strongly protective in men (about 68% lower mortality risk in the highest tertile compared to the lowest) but showed the opposite trend in women. This sex-dependent pattern remains poorly understood and reinforces the importance of interpreting MCH within the full clinical picture.

When Results Can Be Misleading

MCH is one of the most stable blood parameters, with a within-person variation of only about 1.3 to 1.9% over periods ranging from days to a full year. This means a genuine shift of even a few percentage points is likely real. Still, a few situations can produce misleading readings.

• Elevated blood lipids (hyperlipidemia): High cholesterol or triglyceride levels can artificially inflate MCH on some lab analyzers, producing a falsely elevated reading that does not reflect true hemoglobin content.
• Combined nutrient deficiencies: If you are low in both iron and B12 simultaneously, the opposing effects on cell size can cancel each other out, producing a normal-looking MCH that hides two separate deficiencies.
• Medications that deplete B12 over time: Metformin and proton pump inhibitors (common heartburn drugs) can gradually cause B12 deficiency after years of use, slowly pushing MCH upward. The change is real but the cause is often missed if these medications are not considered.
• Inflammation masking iron deficiency: When your body is fighting infection or chronic inflammation, ferritin (the usual marker for iron stores) can rise even when iron is actually low. MCH may be a more reliable signal of true iron status in these situations, though it only drops in longstanding deficiency.

Tracking Your Trend

Because MCH reflects the hemoglobin content of red blood cells that live about 120 days, changes happen slowly. A single reading gives you a useful starting point, but serial measurements reveal the direction your body is heading. This is especially valuable if you are making dietary changes, starting iron or B12 supplementation, or managing a condition that affects blood cell production.

A clinically meaningful change in MCH requires a shift of roughly 3.6 to 5.3%, based on biological variation data. Anything smaller than that is likely normal fluctuation. For context, on a baseline of 30 pg, you would need to see a change of at least 1.1 to 1.6 pg before concluding something real has shifted.

Get a baseline reading, retest in 3 to 6 months if you are making changes to diet, supplements, or medications, and then at least annually after that. If your MCH is outside the normal range, retest sooner (within 4 to 8 weeks) along with iron studies, B12, and folate to identify the root cause. Because red blood cells turn over slowly, do not expect MCH to respond to an intervention for at least 6 to 12 weeks.

MCH's low index of individuality (around 0.3 to 0.4) means your personal baseline is more informative than comparing yourself to population averages. Your own trend line matters more than any single reference range.